Fact CheckerSign in

NCT07355478Recruiting

Asia Myelodysplastic Syndrome (MDS) Registry

Source: ClinicalTrials.gov · Last updated 8 Oct 2026

Brief summary (registry, in English)

The purpose of this study is to provide a contemporary view and offer invaluable insights into the demographic profiles, clinical characteristics, treatments, and real-world outcomes of individuals with myelodysplastic syndromes (MDS) in Asia.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
28 Nov 2025
Start date
11 Aug 2026
Primary completion date
31 Oct 2026
Lead sponsor
Bristol-Myers Squibb
NCT number
NCT07355478

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 11 Aug 2026 to the primary completion date, 31 Oct 2026
  • 3 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • None

Who the study is looking for

  • Retrospective enrolment of Myelodysplastic Syndrome (MDS) participants:
  • Aged at least 18 years at initial diagnosis of MDS
  • Diagnosed with MDS according to World Health Organization (WHO) 2008, WHO 2016, or WHO 2022 criteria between 1 January 2019 and 31 December 2022; and
  • Diagnosed with MDS within 100 days from the date of diagnostic bone marrow (BM) aspirate
  • Aged at least 18 years at initial diagnosis of MDS; and
  • Diagnosed with MDS according to World Health Organization (WHO) 2008, WHO 2016, or WHO 2022 criteria between 1 October 2025 and 30 September 2026; and
  • Diagnosed with MDS within 100 days from the date of diagnostic BM aspirate

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Local Institution - 002
Coordinator of this site? Confirm its status
SeoulSouth KoreaNot yet recruiting
Singapore General Hospital
Coordinator of this site? Confirm its status
SingaporeSingaporeRecruiting
Local Institution - 0001
Coordinator of this site? Confirm its status
TaipeiTaiwanNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.